Review Article
Current Landscape of Epigenetics in Lung Cancer: Focus on the Mechanism and Application
Table 3
miRNAs deregulated in lung cancer.
| miRNA | Mechanism | Clinical utility | Expression level | References |
| miR-21 | Apoptosis | Prognostic biomarker; therapeutic target | Upregulated | [70,120] | miR-495 | Proliferation; migration; invasion; EMT; drug resistance | Therapeutic target | Downregulated | [22] | miR-661 | Invasion; metastasis | Therapeutic target | Upregulated | [72,121] | miR-3607-3p | Cell cycle; metastasis | Prognostic biomarker; therapeutic target | Downregulated | [122] | miR-181b | Migration; invasion | Therapeutic target | Downregulated | [26] | miR -19 | Proliferation; migration | Therapeutic target | Upregulated | [23] | miR-182 | Cell cycle; apoptosis | Diagnostic/prognostic biomarker | Upregulated | [123] | miR-505-5p | Proliferation; apoptosis | Diagnostic biomarker | Upregulated | [124] | miR-1290 | Metastasis | Prognostic biomarker | Upregulated | [125] | miR-CHA1 | Proliferation; apoptosis | Therapeutic target | Downregulated | [126] | miR-193a-3p, miR-210-3p, miR-5100 | Metastasis; EMT | Diagnostic biomarker | Upregulated | [33] | miR-374b | Apoptosis | Therapeutic target | Downregulated | [37] |
|
|